Health Care/Hospital

VizibleZone Signs Contract with the Israeli National Water Company to Provide COVID-19 Exposure Notification Solution

Mobile solution allows companies to monitor and prevent spread of Covid-19 JERUSALEM, Jan. 25, 2021 /PRNewswire/ -- Jerusalem-based Artificial Intelligence (AI) startupVizibleZone  today announced a deal withMekorot , Israel's Natio...

2021-01-25 16:00 1129

European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

- BAVENCIO maintenance treatment significantly extended median overall survival versus standard of care in the Phase III JAVELIN Bladder 100 study - First and only immunotherapy to demonstrate a significant overall survival benefit in the first-line setting in a Phase III trial   - BAVENCIO firs...

2021-01-25 15:00 4095

Dada Group secures necessities supply in Shijiazhuang during COVID-19 outbreak -- Chinese National TV Reported

SHANGHAI, Jan. 24, 2021 /PRNewswire/ -- Dada Group (Nasdaq: DADA) ("Dada" or the "Company"),China's leading local on-demand delivery and retail platform, is working with retailers and brands to provide safe, contactless on-demand delivery service inShijiazhuang, Hebei Province, to combat with the...

2021-01-25 11:29 3714

Boehringer Ingelheim named Top Employer in Malaysia, across Southeast Asia, and South Korea for 2021

KUALA LUMPUR, Malaysia, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inMalaysia and six other countries acrossAsia - Indonesia, Philippines, Singapore, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on exce...

2021-01-25 10:00 1886

Boehringer Ingelheim named Top Employer in Vietnam, across Southeast Asia, and South Korea for 2021

HO CHI MINH CITY, Vietnam, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inVietnam and six other countries acrossAsia - Indonesia, Malaysia, Philippines, Singapore, South Korea andThailand - by Top Employers Institute, the global authority on ex...

2021-01-25 10:00 1993

Boehringer Ingelheim named Top Employer in Philippines, across Southeast Asia, and South Korea for 2021

MAKATI CITY, Philippines, Jan. 25, 2021 /PRNewswire/ --  Boehringer Ingelheim has been recognized as a Top Employer for 2021 inPhilippines and six other countries acrossAsia - Indonesia, Malaysia, Singapore, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on ex...

2021-01-25 10:00 1767

Boehringer Ingelheim named Top Employer in Singapore, across Southeast Asia, and South Korea for 2021

SINGAPORE, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inSingapore and six other countries across Asia - Indonesia, Malaysia, Philippines, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on excellence in peo...

2021-01-25 10:00 2134

Boehringer Ingelheim named Top Employer in Thailand, across Southeast Asia, and South Korea for 2021

BANGKOK, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inThailand and six other countries across Asia - Indonesia, Malaysia, Philippines, Singapore, South Korea and Vietnam - by Top Employers Institute, the global authority on excellence in peop...

2021-01-25 10:00 1740

Boehringer Ingelheim named Top Employer in Indonesia, across Southeast Asia, and South Korea for 2021

JAKARTA, Indonesia, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inIndonesia and six other countries across Asia - Malaysia, Philippines, Singapore, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on excellen...

2021-01-25 10:00 1832

(Interview) OCB Life's Harry Pham shares about his business, future investments, as well as his passion for supercars and football.

HO CHI MINH CITY, Vietnam, Jan. 25, 2021 /PRNewswire/ -- Harry Pham, Chairman of OCB Life Group, and his senior management team attended the Reunion Dinner event organized by the Singapore Business Group at Le Méridien Saigon Hotel on January 23, 2021, together with more than 200 guests who attend...

2021-01-25 09:46 1715

Antengene Announces Approval of IND Application in China for ATG-010 (Selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study

SHANGHAI and HONG KONG, Jan. 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...

2021-01-25 08:20 2375

HistoIndex Explores the Clinical Utility of Stain-free AI Digital Pathology Platform in 388 Patients with Triple-Negative Breast Cancer (TNBC)

SINGAPORE, Jan. 25, 2021 /PRNewswire/ -- HistoIndex 's stain-free AI digital pathology platform, incorporating Second Harmonic Generation (SHG), holds promise as a quantitative tool in the assessment of morphological and architectural changes in collagen fibers w...

2021-01-25 06:00 1632

New Zealand team creates world-first innovation in the fight against Coronavirus

AUCKLAND, New Zealand, Jan. 22, 2021 /PRNewswire/ -- Datamine, a New Zealand based AI company, has createdëlarm: a personal early warning indicator for viral infection, includingCoronavirus. The ëlarm system overcomes what is arguably our greatest obstacle – viral spread by asymptomatic people wh...

2021-01-23 00:41 2713

Happiness Biotech Announces Financial Results for the Six Months Ended September 30, 2020 and Provides Guidance For the Whole Fiscal Year Ending March 31, 2021

NANPING, China, Jan. 22, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, today announced its unaudited financial results for the six months endedSeptember 30, 2020 and provided the guida...

2021-01-22 21:00 11179

MediWelcome Soars 26% in Trading Debut

HONG KONG, Jan, 22, 2021 /PRNewswire/ -- Mediwelcome Healthcare Management & Technology Inc. ("MediWelcome") commenced trading of its shares on the Main Board of SEHK on19 Jan, 2021. The stock code of MediWelcome is 2159. Shares of MediWelcome were actively traded and opened atHK$4.00, up 33% aga...

2021-01-22 19:39 11735

Nanoform's Clinical Study Indicates Positive Interim Results

HELSINKI, Jan. 22, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful. Nanoform has received...

2021-01-22 15:43 1580

Elekta divests its stake in ViewRay

STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction. The shares in ViewRay were purchase...

2021-01-22 14:51 4868

GS1 HK and Zenecom join hands to help local merchants seize trillions O2O opportunities in Mainland medical, healthcare and beauty markets

HONG KONG, Jan. 22, 2021 /PRNewswire/ -- GS1 Hong Kong (GS1 HK) and Zenecom International Group Co. Ltd (Zenecom) formally signed a strategic cooperation agreement to launch "HK Trusted Market + WJH" initiative. Capitalising on the cross-border "Big Health" e-commerce platform WJH, the programme ...

2021-01-22 14:25 2200

DWHP Announces Extension of The Expiration Time of Its Tender Offer

PARK CITY, Utah, Jan. 22, 2021 /PRNewswire/ -- DW Healthcare Partners V, L.P. (" DWHP"), announced today that it is extending the expiration time of its previously announced cash tender offer (the "Tender Offer") in the Offer to Purchase datedDecember 21, 2020 ("Offer to Purchase") for all of the ...

2021-01-22 12:34 9496

Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19

TAIPEI and SAN DIEGO, Jan. 21, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that the first patient has enrolled into an investi...

2021-01-22 12:00 1599
1 ... 567568569570571572573 ... 808